2021
DOI: 10.1016/j.thromres.2021.03.011
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 in thrombosis research: An editorial perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 67 publications
0
1
0
Order By: Relevance
“…Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, caused by the SARS-CoV-2 virus in 2019 [1] it has become apparent that one of the features of COVID-19 is thrombosis (popularly known as blood clots) [2]. Several studies confirmed the observation made by initial publications on thrombotic complications in COVID-19 patients that a diagnosis of thromboembolism per se was associated with a more complicated in-hospital clinical course, higher incidence of admittance to the intensive care unit and higher all-cause mortality [ 3] . However, the early identification of patients at risk of thrombosis is still a challenge.…”
Section: Introductionmentioning
confidence: 93%
“…Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, caused by the SARS-CoV-2 virus in 2019 [1] it has become apparent that one of the features of COVID-19 is thrombosis (popularly known as blood clots) [2]. Several studies confirmed the observation made by initial publications on thrombotic complications in COVID-19 patients that a diagnosis of thromboembolism per se was associated with a more complicated in-hospital clinical course, higher incidence of admittance to the intensive care unit and higher all-cause mortality [ 3] . However, the early identification of patients at risk of thrombosis is still a challenge.…”
Section: Introductionmentioning
confidence: 93%